|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2004-9-16
|
|
pubmed:abstractText |
Our objectives were (1) to develop a population pharmacokinetic model for cyclophosphamide, 4-hydroxycyclophosphamide, and carboxyethylphosphoramide mustard (a reporter for nonrelapse mortality) in hematopoietic stem cell transplantation patients and (2) to validate a Bayesian approach to dosing.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0009-9236
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
270-80
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15371987-Adolescent,
pubmed-meshheading:15371987-Adult,
pubmed-meshheading:15371987-Area Under Curve,
pubmed-meshheading:15371987-Child,
pubmed-meshheading:15371987-Child, Preschool,
pubmed-meshheading:15371987-Cyclophosphamide,
pubmed-meshheading:15371987-Female,
pubmed-meshheading:15371987-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:15371987-Humans,
pubmed-meshheading:15371987-Male,
pubmed-meshheading:15371987-Middle Aged,
pubmed-meshheading:15371987-Models, Biological,
pubmed-meshheading:15371987-Phosphoramide Mustards,
pubmed-meshheading:15371987-Transplantation Conditioning,
pubmed-meshheading:15371987-Whole-Body Irradiation
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Diminishing the risk of nonrelapse mortality in hematopoietic stem cell transplantation: Prediction of exposure to the cyclophosphamide metabolite carboxyethylphosphoramide mustard.
|
|
pubmed:affiliation |
Department of Pharmaceutics, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
